NewAmsterdam Pharma Company N.V. NAMS
NAMS
NewAmsterdam Pharma Company N.V. KYMR
Kymera Therapeutics, Inc. VKTX
Viking Therapeutics, Inc. IMVT
Immunovant, Inc. AKRO
Akero Therapeutics, Inc. CRNX
Crinetics Pharmaceuticals, Inc. ACLX
Arcellx, Inc. PRAX
Praxis Precision Medicines, Inc. LGND
Ligand Pharmaceuticals Incorporated SLNO
Soleno Therapeutics, Inc.
NewAmsterdam Pharma Company N.V. KYMR
Kymera Therapeutics, Inc. VKTX
Viking Therapeutics, Inc. IMVT
Immunovant, Inc. AKRO
Akero Therapeutics, Inc. CRNX
Crinetics Pharmaceuticals, Inc. ACLX
Arcellx, Inc. PRAX
Praxis Precision Medicines, Inc. LGND
Ligand Pharmaceuticals Incorporated SLNO
Soleno Therapeutics, Inc.
Performance
| Periode | NAMS | KYMR | VKTX | IMVT | AKRO | CRNX | ACLX | PRAX | LGND | SLNO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 76.59 % | 80.82 % | 32.12 % | 71.70 % | -1.97 % | 58.28 % | 3.79 % | 525.26 % | 68.22 % | -36.12 % |
| YTD | 34.35 % | 107.13 % | -13.37 % | 5.58 % | 94.62 % | -4.20 % | -15.53 % | 244.48 % | 78.44 % | 9.21 % |
| 1Y | 41.14 % | 96.69 % | -24.58 % | -3.74 % | 86.97 % | -9.60 % | -20.26 % | 278.46 % | 58.14 % | 4.15 % |
| 3Y | 225.49 % | 199.70 % | 786.08 % | 67.17 % | 16.40 % | 193.08 % | 108.85 % | 700.96 % | 208.81 % | 999.56 % |
| 5Y | 228.65 % | 33.15 % | 446.33 % | -48.47 % | 97.58 % | 254.77 % | 295.95 % | -58.34 % | 102.01 % | -64.97 % |
| 10Y | 228.65 % | 154.64 % | 1 572.32 % | 167.30 % | 198.31 % | 101.49 % | 295.95 % | -34.31 % | 73.70 % | -91.98 % |
| Depuis le début | 228.65 % | 154.64 % | 345.26 % | 167.30 % | 198.31 % | 101.49 % | 295.95 % | -34.31 % | 321.95 % | -96.57 % |